Scribd Logo
Carica

Benvenuto in Scribd!

  • Jenburkt Q2FY15

    Caricato da

    Rajesh Vora
    7 visualizzazioni4 pagine
    Quarterly results

    Copyright

    © © All Rights Reserved

    Formati disponibili

    PDF o leggi online da Scribd

    Hai trovato utile questo documento?

    Questo contenuto è inappropriato?

    Segnala questo documento
    Quarterly results

    Copyright:

    © All Rights Reserved
    Scarica in formato PDF o leggi online su Scribd
    Segnala contenuti inappropriati
    7 visualizzazioni4 pagine

    Jenburkt Q2FY15

    Caricato da

    Rajesh Vora
    Quarterly results

    Copyright:

    © All Rights Reserved
    Scarica in formato PDF o leggi online su Scribd
    Segnala contenuti inappropriati
    di 4
    GEJENBURKT Jenburkt Pharmaceuticals Ltd. oh Rd os al POBox. 7396, NurbolAOOOS8 Pn: 6 60960 0D ne “Fou 912268043127 weniviorticom GIN No. 1247304 susp] coneEAt ‘Seandavone Unavalted Fania Resus Yor the Quarter & Walt Year Ended on 3070972014 PART isn cacs except per share Oa [sens Fate care Fae Tf Yer Ended [Year Fad sunt] sonar | somos [sonsis s00sra] suman ‘Urauded aed | “a [income from Operations =) NetSstesincome from Opeatons | o222.0| ae20.a)_sa7ae7| a3aa3a) seraaa| 7620. [1 other Operating come ass 17a ova] —a07] 23] 2.0] [rotalincome fom Operations Net) | 222n35| T092.65| 1675.65] aiv.0n| ewo-] 762.65) 7 |espenses a) cost of ators Consume Tear] 355) ea 3e| TORT osoa) —DaTAA 1b) Purchases of Stock n Trade ‘oa7| oa] oo0f 135] ooo) 08 [cb changes in aventors of ished Jcoods, workinprogessandstoctin- | 720) 2aaa} sis) 2.69] rana0] 07 rade a employee Bante Expense 523] 19895] ai000) oiscal seca] vasa] Ne) Depron nd amortsauen Expense | —8.sol — 370l — 39.00] 06.0] 75.00] — 2263 If omer Expenses @26.1} soso) 5434) 3334.35] 1005] 2200.13 [oral expenses ex0cr| 08.80] —Tere7] 3505 2304.00] ene] 3 Pet trom Operations before wher |ncome, nance eos and exceptional 2) _fotecincome Taal ea] —sa79| sar] aaa) — Tea '5 Plt im Oriya before finance costs and exceptional ems (ass) | 42846] 22030) 23557] unas] s2aar] sas7s soars} 21385] 25879] s1758| 06.40] 99627] frat ec rte fstatocccmimlienets | 2351] xmas] sur] eid ease] sonal sperms a a oe ech taen temo asso! aon] ase] zz] eta see Hr pispee cma mer |e oat ea al — oes 3 fie oy frecccensanctanien | oof say asd roid oof sa GSVENBURKT Jenburkt Pharmaceuticals Lt fd Ofer, a RO. Box 37396 Mab 40058, «Phone 6703 400i) F912 4943127 ‘weno EIN No: SOUP TDGPLCONG6At PART THFORIATION FORTHE GUARTER AND HALF YEAR ENDED ON SOOS07H ‘Quarter Ended [Wallyer Ende Year Ended sno Parcs unorra] sowars [samp | sani [sonar] site ce 4} Pubic enaehoxing umber of hares 2495223] 2400823) 2ass4se| zassz23)2486450| 2472800 Percentage of stareholng soos] sooo! 5940] sacs) saagl 2] Promotare and Promoter Gop |snsrchaaing ') Pasig Encumbred Number of ebaree * Porcertage of shares (68 fhe {otal sharolig of promoter end prometer gro) “Percentage of sacs esa otthe | ‘otal share opt oft soar ») Non encumbered - Porcentage of shares (ea % ofthe ‘otal shareheang ot ne Rematerane} s00.00) 10000] 10000) ton.00) 100.09 Promoter grup) = Percentage shares (a % ofthe foalshaeceptalstttacomeany) | aeos) 460i] 4552} 4ae) a. = Number of aaret zrasur7| 21e2s77| 2162602|2vesor7| ts2sea) 21761] Partours Toa _RVESTOR COMPLAINTS Penns ate being of he euarer wi Recowvod curing the quarter 4 Disposed of ing he quarter 4 Remaining urcesovod at the et ofthe st ‘Nor 1. The shove unsuited rents were evlewed bythe Aut Committe a taken on record by he Board ofiectos of the Company at thee spective meetings held 0 1th November, 2014 “he Litd Review ofthe quater results hasbeen cri uty the Statutory Autos gures of previous quarers/ year are e-grouped/tearange, wherever necessary. ‘The Companys dealing excshly i pharmaceuticals Formulation buses segment hence segments presentation offal est snot equred 5. Dividend @ R510 (518) pee Repaid up equity share was pai, dving the quarter, amounting to 5237-14301. Durog the af year the companyhas implemented Schedule ifthe Companies At, 2013 and ‘secrding has computed the detection as prescribed by Schedule to the Actor actual sale ‘fasts, whichever wer The carrying vale fates which hs competed ts dpreition period 25 on Api, 2014 hasbeen adjusted othe General serve. The remaining assets have been depreciate over the evied use fe and a result higher deprecation hasbeen recngnzed as hargeln the Statement of Poftand Loss for half year ended Saperber 30,2014 z GAJENBURKT Jenburkt Pharmaceuticals Ltd. og tc: 9 yoshi hl PO. Box 37396, Marl -400058. Phone: 67 4636800) =F 9)-2.6804 3127 ‘enim ‘CIN Wo.: L2dBsoniH9asPLCORGS41 (one [SNe [Paricuare Taare [sina ‘A. JeQUITY & LIABILITIES snare Hotaors Fund [shar cepts 404 «5409 fb Reserves & Supt arta} 228.79 > Money Receve aan rare warrants 0 ° ‘Subota Shaoholsers fund Sie2aa) 27901 2|shereapptzaten more pening stent 0 8 fino interost oo ° ‘fvion Curent Liab fs) Long Term Boronigs 1.0] 26 >) Defra Tax Listy (et) soe 1049] = otner Lon Term Lines are 2709] 3) Long Term rowsione 215.59 sical ‘Sub tota Non current bias Tie6 af 05.9 sfeurrontLisbites Js) Sor ex Borowinge aan +035] >) eae Payabies osc] 410.29 ) Oher Cure Listes corsa] aan] Shot! Tem Povisins eooo] 576.0) Sub total Curont itis 540.8) tera. ‘TOTAL -EQUTY AND LIABILITIES saisoi) 5200. 8. fassers sion Curent Assets |.) Fas Ascte szroei] ——ras704 J) Non current invastuents 123] 3123] |) ceteros Tax Aces Nt) 0.9 09 |) Long Term Loans &Aavances 0.09 0.09 2) ome Non curenasets 0.09 03 ‘Sub fota Non-currentassats ‘oz05] Tae fount Assets :) currrtnvestrents ° ° > rveres mH 503 >) rade Reseiabine S20. 4091 [2 cash Caan Equant reas] 1874 ) shor'Term Loans &Advancos 5924 02] fp otter curen Assess 106073 ers ‘Subtotal -Curont sets 286 3576 yonder ofthe Board, For Jenburkt Pharmaceuticals id Aer tes Paco: Mumbai (shish U. Bhat) Dale 1/014 (Cen nd Managing Director 191425, BHAGYODAYA, D.L.ARORA & Co. Snort each, ‘MUMBA 400 081, CHARTERED ACCOUNTANTS TEL: 32911248 FAK 26474719 LIMITED REVIEW REPORT “THEBOARD OF DIRECTORS, JENBURKT PHARMACEUTICALS LIMITED, ‘Nimala Apartments, 9047. Road, Andheri West, Mab -40008, We have reveved the ecompanying statement of und Anacll resus of JENBURKT PHARMACEUTICALS LIMITED forthe urter ended September 30%, 2014 except fr the

    Potrebbero piacerti anche